Neuroimaging of structural pathology and connectomics in traumatic brain injury: Toward personalized outcome prediction☆
Aylward, Stephen R.
Prastawa, Marcel W.
Pace, Danielle F.
Hovda, David A.
Vespa, Paul M.
Van Horn, John D.
MetadataShow full item record
CitationIrimia, Andrei, Bo Wang, Stephen R. Aylward, Marcel W. Prastawa, Danielle F. Pace, Guido Gerig, David A. Hovda, Ron Kikinis, Paul M. Vespa, and John D. Van Horn. 2012. “Neuroimaging of structural pathology and connectomics in traumatic brain injury: Toward personalized outcome prediction☆.” NeuroImage : Clinical 1 (1): 1-17. doi:10.1016/j.nicl.2012.08.002. http://dx.doi.org/10.1016/j.nicl.2012.08.002.
AbstractRecent contributions to the body of knowledge on traumatic brain injury (TBI) favor the view that multimodal neuroimaging using structural and functional magnetic resonance imaging (MRI and fMRI, respectively) as well as diffusion tensor imaging (DTI) has excellent potential to identify novel biomarkers and predictors of TBI outcome. This is particularly the case when such methods are appropriately combined with volumetric/morphometric analysis of brain structures and with the exploration of TBI-related changes in brain network properties at the level of the connectome. In this context, our present review summarizes recent developments on the roles of these two techniques in the search for novel structural neuroimaging biomarkers that have TBI outcome prognostication value. The themes being explored cover notable trends in this area of research, including (1) the role of advanced MRI processing methods in the analysis of structural pathology, (2) the use of brain connectomics and network analysis to identify outcome biomarkers, and (3) the application of multivariate statistics to predict outcome using neuroimaging metrics. The goal of the review is to draw the community's attention to these recent advances on TBI outcome prediction methods and to encourage the development of new methodologies whereby structural neuroimaging can be used to identify biomarkers of TBI outcome.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11878927
- HMS Scholarly Articles 
Showing items related by title, author, creator and subject.
Increased diffusivity in superior temporal gyrus in patients with schizophrenia: A Diffusion Tensor Imaging study Lee, KangUk; Yoshida, Takeshi; Kubicki, Marek R.; Bouix, Sylvain; Westin, Carl-Fredrik; Kindlmann, Gordon; Niznikiewicz, Margaret A.; Cohen, Adam Brian; McCarley, Robert William; Shenton, Martha Elizabeth (Elsevier BV, 2009)Background: Superior temporal gyrus (STG) volume reduction is one of the most consistent findings in schizophrenia. The goal of this study was to conduct the first diffusion tensor imaging (DTI) study to investigate altered ...
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma ELLINGSON, BENJAMIN M.; KIM, EUNHEE; WOODWORTH, DAVIS C.; MARQUES, HELGA; BOXERMAN, JERROLD L.; SAFRIEL, YAIR; McKINSTRY, ROBERT C.; BOKSTEIN, FELIX; JAIN, RAJAN; CHI, T. LINDA; SORENSEN, A. GREGORY; GILBERT, MARK R.; BARBORIAK, DANIEL P. (D.A. Spandidos, 2015)Functional diffusion mapping (fDM) is a cancer imaging technique that quantifies voxelwise changes in apparent diffusion coefficient (ADC). Previous studies have shown value of fDMs in bevacizumab therapy for recurrent ...
Whitford, Thomas; Kubicki, Marek R.; Shenton, Martha E. (Hindawi Publishing Corporation, 2011)A fundamental tenet of the “disconnectivity” theories of schizophrenia is that the disorder is ultimately caused by abnormal communication between spatially disparate brain structures. Given that the white matter fasciculi ...